BioInformant Worldwide, L.L.C.

BioInformant Worldwide, LLC, situated in the United States, is a distinguished research entity specializing in delivering market intelligence tailored for the dynamic stem cell industry. Uniquely positioned, they stand as the sole company dedicated to serving the stem cell sector since its inception. This distinctive focus empowers them to generate comprehensive data that equips clients with enhanced insights into markets, competitors, and customer dynamics.

Over time, BioInformant has earned notable recognition, having been prominently featured in renowned news outlets such as Nature Biotechnology, the Wall Street Journal, CBS News, Yahoo Finance, Medical Ethics, MarketWatch, the Center for BioNetworking, and various others.

The leadership team at BioInformant possesses a background in BioInformatics, a discipline centered on intricate genetic code collection and analysis.
Their adeptness in applying these advanced data analysis techniques to market research solidifies their standing in the industry.

Functioning as a dedicated stem cell research firm, BioInformant leverages cutting-edge technology to track and pinpoint lucrative prospects within the stem cell domain. This invaluable data is then furnished to clients striving for aggressive expansion. Serving influential entities including GE Healthcare, Pfizer, Goldman Sachs, Beckton Dickinson, Thermo Fisher Scientific, and numerous others among the Fortune 500, BioInformant stands as the trusted purveyor of authoritative stem cell industry insights.

BioInformant Worldwide, L.L.C.
 

List of reports from BioInformant Worldwide, L.L.C.

Global Cord Blood & Tissue Banking Industry Report – Market Size, Segmentation, & Forecasts, 2024
12/23/2023 | published by: BioInformant Worldwide, L.L.C.
... that year, remarkable achievements have been made regarding research into umbilical cord blood-derived hematopoietic and progenitor cells. To date, more than 40,000 UCB transplants (UCBTs) have been performed across different geographies of the world, in ...  |  read more...
Global CAR-T Cell Therapy Market – Market Size, Forecasts, Trials, and Trends, 2023
11/1/2023 | published by: BioInformant Worldwide, L.L.C.
... collect immune cells, modify them in a laboratory, and provide them the power to easily recognize and kill cancer cells. When infused into a patient, the cells get multiplied and stay in the body as ...  |  read more...
Global Cord Blood & Tissue Banking Industry Report - Market Size, Segmentation, & Forecasts, 2023
10/1/2023 | published by: BioInformant Worldwide, L.L.C.
... banking operators. For both therapeutic and financial reasons, the cord blood industry has been witnessing record levels of merger and acquisition (M&A) activity in recent years, with market leaders gaining market share at the expense ...  |  read more...
Global Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, Trials, and Forecasts, 2023
9/1/2023 | published by: BioInformant Worldwide, L.L.C.
... been made in stem cell biology and regenerative medicine. New pathological mechanisms have been identified and explained, new drugs identified by iPSC screens are in the pipeline, and the first clinical trials employing human iPSC-derived ...  |  read more...
Mesenchymal Stem Cells / Medicinal Signaling Cells (MSCs) – Advances & Applications, 2023
9/1/2023 | published by: BioInformant Worldwide, L.L.C.
... chondrocytes, myocytes, and adipocytes. In addition to secreting factors that can stimulate tissue repair, MSCs can substantially alter their microenvironment, exerting effects that are both anti-inflammatory and anti-fibrotic. MSCs are advantageous over other cell types ...  |  read more...
Global Cord Blood & Tissue Banking Industry Report - Market Size, Segmentation, & Forecasts, 2023
9/1/2023 | published by: BioInformant Worldwide, L.L.C.
... banking operators. For both therapeutic and financial reasons, the cord blood industry has been witnessing record levels of merger and acquisition (M&A) activity in recent years, with market leaders gaining market share at the expense ...  |  read more...
The Global Exosome Market – Market Size, Forecast, Trials and Trends, 2023
5/1/2023 | published by: BioInformant Worldwide, L.L.C.
... by a wide range of cells, since virtually all living cells utilize exosome-mediated communication. Exosomes carry cell-specific cargos of proteins, lipids, and nucleic acids that are selectively taken up by recipient cells. Exosome technologies have ...  |  read more...
USD 4,497
Mesenchymal Stem Cells / Medicinal Signaling Cells (MSCs) – Advances & Applications, 2023
5/1/2023 | published by: BioInformant Worldwide, L.L.C.
... chondrocytes, myocytes, and adipocytes. In addition to secreting factors that can stimulate tissue repair, MSCs can substantially alter their microenvironment, exerting effects that are both anti-inflammatory and anti-fibrotic. MSCs are advantageous over other cell types ...  |  read more...
USD 4,297
The Global Exosome Market – Market Size, Forecast, Trials and Trends, 2023
3/1/2023 | published by: BioInformant Worldwide, L.L.C.
... by a wide range of cells, since virtually all living cells utilize exosome-mediated communication. Exosomes carry cell-specific cargos of proteins, lipids, and nucleic acids that are selectively taken up by recipient cells. Exosome technologies have ...  |  read more...
USD 4,497
The Global Exosome Market – Market Size, Forecast, Trials and Trends, 2022
12/1/2022 | published by: BioInformant Worldwide, L.L.C.
... integrated into the fields of liquid biopsy, precision medicine and regenerative medicine. In particular, cancer derived exosomes influence the invasive potential of cells by regulating angiogenesis, metastasis, and immunity, making them an extremely useful source ...  |  read more...
USD 4,497
The Global Market for Cultured Meat – Market Size, Trends, Competitors, and Forecasts (2022)
9/1/2022 | published by: BioInformant Worldwide, L.L.C.
... produced by growing master cells collected from cattle, chicken, pigs, fish, and lamb, as well as other types of livestock and seafood. In addition to meat and seafood production, cultured meat techniques can be used ...  |  read more...
USD 4,197
The Global Exosome Market – Market Size, Forecast, Trials and Trends, 2022
8/1/2022 | published by: BioInformant Worldwide, L.L.C.
... integrated into the fields of liquid biopsy, precision medicine and regenerative medicine. In particular, cancer derived exosomes influence the invasive potential of cells by regulating angiogenesis, metastasis, and immunity, making them an extremely useful source ...  |  read more...
USD 4,497
Mesenchymal Stem Cells - Advances and Applications, 2022
4/1/2022 | published by: BioInformant Worldwide, L.L.C.
... and adipocytes. In addition to secreting factors that can stimulate tissue repair, MSCs can substantially alter their microenvironment, exerting effects that are both anti-inflammatory and anti-fibrotic. MSCs are advantageous over other stem cells types for ...  |  read more...
USD 3,997
Global CAR-T Cell Therapy Market – Market Size, Forecasts, Trials & Trends, 2022
12/1/2021 | published by: BioInformant Worldwide, L.L.C.
... collect immune cells, modify them in a laboratory, and provide them the power to easily recognize and kill cancer cells. When infused into a patient, the cells get multiplied and stay in the body as ...  |  read more...
USD 3,997
Global Cord Blood and Tissue Banking Industry Report 2021
11/1/2021 | published by: BioInformant Worldwide, L.L.C.
... therapeutic and financial reasons, the cord blood industry has been witnessing record levels of merger and acquisition (M&A) activity in recent years, with market leaders gaining market share at the expense of smaller competitors and ...  |  read more...
USD 3,997
The Global Exosome Market – Market Size, Forecast, Trials, and Trends, 2021
8/1/2021 | published by: BioInformant Worldwide, L.L.C.
... they get integrated into the fields of liquid biopsy, precision medicine and regenerative medicine. In particular, cancer derived exosomes influence the invasive potential of cells by regulating angiogenesis, metastasis, and immunity, making them an extremely ...  |  read more...
USD 3,997
Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report, 2021
8/1/2021 | published by: BioInformant Worldwide, L.L.C.
... regenerative medicine. New pathological mechanisms have been identified and explained, new drugs identified by iPSC screens are in the pipeline, and the first clinical trials employing human iPSC-derived cell types have been initiated. iPSCs can ...  |  read more...
USD 3,997
Mesenchymal Stem Cells - Advances and Applications, 2021
8/1/2021 | published by: BioInformant Worldwide, L.L.C.
... and adipocytes. In addition to secreting factors that can stimulate tissue repair, MSCs can substantially alter their microenvironment, exerting effects that are both anti-inflammatory and anti-fibrotic. MSCs are advantageous over other stem cells types for ...  |  read more...
USD 3,997
The Market for Cell and Gene Therapy Manufacturing – The Rise of CMOs & CDMOs (2021)
6/1/2021 | published by: BioInformant Worldwide, L.L.C.
... therapy companies on a contract basis. Contract development and manufacturing organizations (CDMOs) are similar, in that they offer services that include cell therapy product development, manufacturing, clinical trial support, and commercial supply. Among cell and ...  |  read more...
USD 1,297
Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report, 2021
6/1/2021 | published by: BioInformant Worldwide, L.L.C.
... regenerative medicine. New pathological mechanisms have been identified and explained, new drugs identified by iPSC screens are in the pipeline, and the first clinical trials employing human iPSC-derived cell types have been initiated. iPSCs can ...  |  read more...
USD 4,797
Global CAR-T Cell Therapy Market – Market Size, Forecasts, Trials & Trends, 2021
6/1/2021 | published by: BioInformant Worldwide, L.L.C.
... collect immune cells, modify them in a laboratory, and provide them the power to easily recognize and kill cancer cells. When infused into a patient, the cells get multiplied and stay in the body as ...  |  read more...
USD 3,997
The Global Exosome Market – Market Size, Forecast, Trials, and Trends, 2021
5/15/2021 | published by: BioInformant Worldwide, L.L.C.
... they get integrated into the fields of liquid biopsy, precision medicine and regenerative medicine. In particular, cancer derived exosomes influence the invasive potential of cells by regulating angiogenesis, metastasis, and immunity, making them an extremely ...  |  read more...
USD 3,997
Global Cord Blood Banking Industry Report 2021
1/5/2021 | published by: BioInformant Worldwide, L.L.C.
... From 2005 to 2010, the market reached saturation and stabilized. From 2010 to 2020, the market began to aggressively consolidate, creating both threats and opportunities within the industry. Serious threats to the industry include low ...  |  read more...
USD 3,997
 
US: 800.298.5699
Int'l: +1.240.747.3093
Live help
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!